Trial intelligence / Profile preview

Rectiv PK and Safety in Adolescents with Chronic Anal Fissure

NCT01920074Phase 4Withdrawn

Sponsor
Forest Laboratories
Start
Jun 2013
Primary completion
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nitroglycerin in chronic anal fissure (CAF), sponsored by Forest Laboratories. Planned start Jun 2013; status: withdrawn.

02

Drugs

nitroglycerin
03

Conditions

chronic anal fissure (CAF)

Beyond the preview

Go deeper on NCT01920074.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01920074.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call